NCT02946749

Brief Summary

As the "two-child" policy implementation, caesarean women's clinical pregnancy is a huge problem again, Especially the placenta planting abnormal disease is a serious threat to the maternal health and life. Through this research, the investigators can obtain relevant epidemiological data and provide objective data for the department of public health policy; Predicting an placenta abnormal planting early diagnosis model was constructed, it will fill the blank in this field, and high-risk groups in the early stages of pregnancy will be taken proper disposal, the related complications will be reduced to ensure the safety of maternal.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2016

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 22, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 27, 2016

Completed
1 month until next milestone

Study Start

First participant enrolled

December 1, 2016

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

August 1, 2017

Status Verified

July 1, 2017

Enrollment Period

2 years

First QC Date

October 22, 2016

Last Update Submit

July 30, 2017

Conditions

Scarred Uterus

Keywords

Scar pregnancyPlacenta planting abnormal diseaseEarly diagnosisIndividualized treatment

Outcome Measures

Primary Outcomes (1)

  • Placenta implanted

    up to 37 gestational weeks

Secondary Outcomes (1)

  • Placenta previa

    up to 37 gestational weeks

Study Arms (4)

Shanghai First Maternity and Infant Hospital

the Putuo District Maternity and Child Health Care Hospital

the Xinhua hospital affiliated to Shanghai jiaotong University

The Sixth people's hospital of Shanghai

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

pregnant women with scar uterus

You may qualify if:

  • Single pregnancies with once cesarean section history
  • see a doctor before gestational 8 weeks in our study center
  • will continue to pregnancy, high patient compliance

You may not qualify if:

  • twins or multiple pregnancies
  • hysteromyoma or adenomyoma stripping history
  • history of intrauterine adhesions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Disease

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Hao Ying, PHD

    Shanghai First Maternity and Infant Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hao Ying, PHD

CONTACT

13371985049stephenying2011@126.com

Chuanlu Xu, Master

CONTACT

13661631960xuchuanlu@foxmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 22, 2016

First Posted

October 27, 2016

Study Start

December 1, 2016

Primary Completion

December 1, 2018

Study Completion

December 1, 2018

Last Updated

August 1, 2017

Record last verified: 2017-07